Results 231 to 240 of about 5,026,401 (367)
Peripheral-central immune interactions in Parkinson's disease: insights into innate and adaptive immunity. [PDF]
Tumpa JJ +3 more
europepmc +1 more source
Biomaterial Strategies for Targeted Intracellular Delivery to Phagocytes
Phagocytes are essential to a functional immune system, and their behavior defines disease outcomes. Engineered particles offer a strategic opportunity to target phagocytes, harnessing inflammatory modulation in disease. By tuning features like size, shape, and surface, these systems can modulate immune responses and improve targeted treatment for a ...
Kaitlyn E. Woodworth +2 more
wiley +1 more source
Fundamental and emerging insights into innate and adaptive immunity in inflammatory bowel diseases. [PDF]
Monteleone G +3 more
europepmc +1 more source
This study presents an injectable hydrogel that responds to Pseudomonas aeruginosa infection by releasing a dual‐phage cocktail on demand. The system degrades selectively in infected wounds, enhances phage localization and stability, and shows potent antibiofilm activity and biocompatibility in an ex vivo human skin model—offering a promising strategy ...
Siyuan Tao +9 more
wiley +1 more source
SnapShot: CRISPR-RNA-Guided Adaptive Immune Systems
Joshua Carter, Blake Wiedenheft
openalex +1 more source
Functional interactions between innate lymphoid cells and adaptive immunity
Gregory F. Sonnenberg, M. Hepworth
semanticscholar +1 more source
Next‐Generation Bio‐Reducible Lipids Enable Enhanced Vaccine Efficacy in Malaria and Primate Models
Structure–activity relationship (SAR) optimization of bio‐reducible ionizable lipids enables the development of highly effective lipid nanoparticle (LNP) mRNA vaccines. Lead LNPs show superior tolerability and antibody responses in rodents and primates, outperforming approved COVID‐19 vaccine lipids.
Ruben De Coen +30 more
wiley +1 more source
Immunopathogenesis of Systemic Lupus Erythematosus: Interplay of Innate and Adaptive Immunity, Microbiome Dysbiosis, and Emerging Therapeutic Targets. [PDF]
Ahmed A, Li S, Yu JJ, Shao WH.
europepmc +1 more source

